+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Esoteric Testing Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 5177954
  • Report
  • August 2020
  • Region: Global
  • 117 pages
  • Mordor Intelligence
until Dec 31st 2020

Enquire about COVID-19 updates for this product.

Enquire Now


  • Arup Laboratories
  • bioMontr Labs
  • Fulgent Genetics Inc.
  • Grifols, S.A.
  • Miraca Holdings Inc.
  • Nordic Laboratories
  • MORE
The esoteric testing market is expected to register a 12 % of CAGR over the forecast period. The key contributors in the market growth are rising cases of infectious and rare diseases and other diseases. According to the European Commission, approximately 27 to 36 million people suffer from rare disease in European region. Also, according to the Centre for Disease Control and Prevnetion, 2017, the number of cases of salmonella were around 54,285. Hence this growing burden of rare diseases is expected to increase the demand for esoteric testing market growth during the forecast period.

Key Market Trends

Oncology Segment is Expected to Exhibit a Significant Market Growth Over the Forecast Period

Oncology is expected to show a healthy growth in the Esoteric Testing Market during the forecast period. The rising importance of early diagnosis and treatment for cancer will impact positively on the market growth in this segment. According to the World Health Organization, cancer is one of the second leading cause of death worldwide. In 2018, around 1.8 million new cases were reported with cancer globally. The most common type of cancers are lung, breast and prostate cancer.

Furthermore, the increasing investments of R&D activities is expected to drive the demand of testing. According to the European Federation of Pharmaceutical Industries and Associations, 2017, the overall sales of pharmaceutical industry worldwide was recorded to be approximately 852,647 million USD. Hence, the aforementioned factors are expected to boost the market growth in this segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Esoteric Testing market owing to increasing number of R&D activities and investments on it. As per the data of National Organization of Rare Diseases, around 30 million people were suffering from some type of diseases (2019). Also, almost one out of ten individuals in America have rare diseases and more than half of these are children. According to the Pharmaceutical Research & Manufacturers of America, in 2018, the R&D expenditure by biopharmaceutical companies was around 79.6 billion USD in the United States. Thus, with growing burden of rare diseases and increasing investment into research and development activities the demand for esoteric testing is expected to propel the market growth in this region.

Competitive Landscape

Some of the well-known companies that are operating in Esoteric Testing market include American Esoteric Laboratories, Quest Diagnostics, Laboratory Corporation of America, bioMontr Labs, Arup Laboratories, Miraca Holdings Inc., Fulgent Genetics Inc., Nordic Laboratories and Grifols, S.A.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown


  • Arup Laboratories
  • bioMontr Labs
  • Fulgent Genetics Inc.
  • Grifols, S.A.
  • Miraca Holdings Inc.
  • Nordic Laboratories
  • MORE
1.1 Study Assumptions
1.2 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Chronic Diseases
4.2.2 Rising Cases of Rare Diseases
4.2.3 Increasing Spending in Research & Development Activities
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Test Type
5.1.1 Endocrinology
5.1.2 Infectious Disease
5.1.3 Oncology
5.1.4 Neurology
5.1.5 Toxicology
5.1.6 Others
5.2 By Technology
5.2.1 Flow Cytometry
5.2.2 Chemiluminescence Immunoassay
5.2.3 Mass Spectrometry
5.2.4 Radio Immunoassay
5.2.5 Others
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 American Esoteric Laboratories
6.1.2 Arup Laboratories
6.1.3 bioMontr Labs
6.1.4 Fulgent Genetics Inc.
6.1.5 Grifols, S.A.
6.1.6 Laboratory Corporation of America
6.1.7 Miraca Holdings Inc.
6.1.8 Nordic Laboratories
6.1.9 Quest Diagnostics

Note: Product cover images may vary from those shown


  • American Esoteric Laboratories
  • Arup Laboratories
  • bioMontr Labs
  • Fulgent Genetics Inc.
  • Grifols, S.A.
  • Laboratory Corporation of America
  • Miraca Holdings Inc.
  • Nordic Laboratories
  • Quest Diagnostics
Note: Product cover images may vary from those shown